ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : GENOMICS
Field of Research : Medical Bacteriology
Clear All
Filter by Field of Research
Medical Bacteriology (31)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (31)
Filter by Status
Closed (31)
Filter by Scheme
Project Grants (20)
Early Career Fellowships (3)
Career Development Fellowships (2)
NHMRC Project Grants (2)
Postgraduate Scholarships (2)
Practitioner Fellowships (1)
Research Fellowships (1)
Filter by Country
Australia (10)
Filter by Australian State/Territory
VIC (6)
QLD (3)
NT (2)
  • Researchers (1)
  • Funded Activities (31)
  • Organisations (16)
  • Funded Activity

    Mechanisms Of Antibiotic-induced Persistent Bacterial Infection

    Funder
    National Health and Medical Research Council
    Funding Amount
    $632,048.00
    Summary
    Golden staph still causes significant human infections and resistance to antibiotics is an ever growing problem with this bacteria. This project will determine how resistance to some antibiotics is also changing the bacteria to promote persistent, difficult to treat infections. The insights from this study will help understand evolution of this bacteria, and help design new strategies for management.
    More information
    Funded Activity

    Reducing Pertussis Burden By Optimising Molecular Epidemiological Surveillance Of Epidemic Bordetella Pertussis In Australia

    Funder
    National Health and Medical Research Council
    Funding Amount
    $487,258.00
    Summary
    Australia has experienced a prolonged epidemic of pertussis from 2008 to 2012 and is currently experiencing another epidemic. In this project, we aim to elucidate the evolutionary dynamics of the epidemics by genome sequencing and develop a practical high throughput culture independent method for epidemiological typing. The outcomes will be highly significant for surveillance of pertussis infections and designing strategies for control and prevention of pertussis.
    More information
    Funded Activity

    New Antbiotics From Old Microbes

    Funder
    National Health and Medical Research Council
    Funding Amount
    $1,005,912.00
    Summary
    Once treatable infections are becoming deadly because bacteria are developing broad antibiotic resistance. New medicines are urgently needed. Microbes themselves are the richest known source of new antibiotics but finding the 'good bugs' is like finding a needle in a microbial haystack. This project will use state-of-the art science to screen a previously overlooked source of rich microbial biodiversity and find new antibiotics.
    More information
    Funded Activity

    Plasmid Specialisation Modules, Microbial Husbandry And Microbiome Resilience

    Funder
    National Health and Medical Research Council
    Funding Amount
    $645,005.00
    Summary
    The epidemiology of plasmids is chiefly determined by small genetic modules that control their entry to cells, their stability after entry, and their capacity to exclude other related plasmids. Understanding this is important for understanding transmission of antibiotic resistance. It is also essential for our newly proven approach to remove resistance plasmids from bacteria.
    More information
    Funded Activity

    Understanding The Disease Burden And Antibiotic Resistance In Patients With Bloodstream Infections Caused By Enterobacteriaceae In Australia

    Funder
    National Health and Medical Research Council
    Funding Amount
    $135,285.00
    Summary
    This study aims to establish the epidemiology of bloodstream infections caused by Enterobacteriaceae (enteric or gut bacteria) in Australia, by examining infection rates, types of antibiotic resistance present, and which treatments optimise clinical outcomes.
    More information
    Funded Activity

    Understanding Virulence Of Invasive Staphylococcus Aureus

    Funder
    National Health and Medical Research Council
    Funding Amount
    $772,711.00
    Summary
    Staph aureus (Golden staph) is a major cause of disease in humans. In this project we will use state-of-the-art molecular biology and genomics to fully understand the mechanisms of virulence in this pathogen. This information will inform future approaches to development of therapeutics, as well as the use of genomics in clinical microbiology and disease management.
    More information
    Funded Activity

    Molecular Epidemiology Of Mycobacterium Tuberculosis Infection In The Northern Territory, Australia

    Funder
    National Health and Medical Research Council
    Funding Amount
    $122,714.00
    Summary
    The Northern Territory (NT) of Australia has the highest jurisdiction-specific rates of tuberculosis (TB) in Australia, and TB is a disease that disproportionately affects Indigenous people. The factors that contribute to the spread of TB in the NT are incompletely understood. We plan to use technology known as “whole genome sequencing” of bacterial DNA to better the understanding of the spread of TB in the NT. This will help guide TB control policies.
    More information
    Funded Activity

    A One Health Approach To Assessing The Threat Of Clostridium Difficile To Australia’s Biosecurity: A Genomic Investigation Of Human, Animal And Environmental Isolates

    Funder
    National Health and Medical Research Council
    Funding Amount
    $318,768.00
    Summary
    Clostridium difficile is a bacterium that causes life-threatening diarrhoea in humans and animals and is a major public health issue in Australia. This project will study the genetic make-up of the bacterium and identify factors contributing to the emergence, evolution, and spread of C. difficile. This knowledge will be essential in guiding effective public health interventions and reducing deaths from C. difficile infection in humans and animals.
    More information
    Funded Activity

    Understanding The Contribution Of SRNAs To Antibiotic Resistance In Staphylococcus Aureus

    Funder
    National Health and Medical Research Council
    Funding Amount
    $587,424.00
    Summary
    Golden Staph is a major problem in Australian hospitals. This project will use cutting edge technology to investigate how Golden Staph responds to and resists antibiotics used to treat human infections, leading to new strategies for the prevention and treatment of antibiotic resistant bacteria.
    More information
    Funded Activity

    Genomic Approaches In Human Health Microbiology

    Funder
    National Health and Medical Research Council
    Funding Amount
    $687,975.00
    Summary
    This project uses latest genomic technologies to advance our understanding of how bacteria cause disease and finding new antibiotics/approaches to stop the spread of multi-drug resistant hospital superbugs.
    More information

    Showing 1-10 of 31 Funded Activites

    • 1
    • 2
    • 3
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback